Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway

  1. Civantos, E.
  2. Bosch, E.
  3. Ramirez, E.
  4. Zhenyukh, O.
  5. Egido, J.
  6. Lorenzo, O.
  7. Mas, S.
Aldizkaria:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

ISSN: 1178-7007

Argitalpen urtea: 2017

Alea: 10

Orrialdeak: 207-222

Mota: Artikulua

DOI: 10.2147/DMSO.S132537 GOOGLE SCHOLAR lock_openSarbide irekia editor